By Colin Kellaher
Axogen's top finance executive, Nir Naor, is leaving the developer of technologies for peripheral nerve regeneration and repair to pursue other interests.
Axogen on Thursday said Naor, who joined the Alachua, Fla., company as chief financial officer in December 2023, will step down from the post effective May 11 but will remain in an advisory capacity through July 1.
The company said Lindsey Hartley, currently vice president and corporate controller, will succeed Naor as finance chief, effective May 12.
Axogen said Hartley, who joined the company in 2021, will receive an annual base salary of $440,000 as chief financial officer, along with an annual bonus plan with a target of 50% of her base pay.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 08, 2025 08:25 ET (12:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。